Psycho-Babble Medication Thread 334079

Shown: posts 1 to 5 of 5. This is the beginning of the thread.

 

Best Docs in US for Treatment-Resistant Depression

Posted by jrbecker on April 8, 2004, at 10:36:39

for those in need of a reference...


http://www.psycom.net/depression.central.html

The Best Psychiatrists in the U.S.A.
Specializing in the Treatment of People with Mood Disorders.

Compiled by, Ivan Goldberg, MD

This is a listing of the top psychiatrists in the U.S.A. specializing in the treatment of individuals with all types of depressive disorders including Bipolar (manic- depressive) Disorder, Cyclothymia, Dysthymia, Major Depression, and other mood disorders.

Rich Charles L, M.D.
3421 Medical Park Drive West
Mobile, AL 36693
251-471-7017


Gelenberg, Alan J., M.D.
Arizona Health Sciences Center
501 N. Campbell Avenue
Tucson, AZ 85724
520-626-6586


Akiskal, Hagop S. M.D.
9500 Gilman Drive
La Jolla, CA 92093
619-552-8585 Extn 2226


Zisook, Sidney M.D.
3350 La Jolla Village Drive
La Jolla, CA 92093
858-534-4040


Gitlin, Michael J., M.D.
300 UCLA Medical Plaza. Ste. 2200
Los Angeles, CA 90095
310-206-6546


Whybrow, Peter C., M.D.
760 Westwood Plaza
Los Angeles, CA 90024
310-206-1233


Pepper, Sanford, M.D.
2266 Union Street
San Francisco, CA 94123
415-931-8199


Schatzberg, Alan F., M.D.
Stanford University School of Medicine
Stanford, CA 94305
650-723-6811


Steven Dubovsky, M.D.
University of Colorado School of Medicine
4200 E. Ninth Avenue
Denver, CO 80262
303-315-8481


Nelson, J. Craig, M.D.
Yale-New haven Hospital
20 York Street
New Haven, CT 06517
203-785-2157


Goodwin, Frederick K., M.D.
George Washington University
2300 I Street NW
Washington, DC 20037
202-994-1014


Sheehan David V, M.D.
University of South Florida
3515 E. Fletcher Avenue
Tampa, FL 33613
305-243-4060


Lieber, Arnold L, M.D.
317 NE 24th Street
Miami, FL 33137
305-576-1515


Nemeroff, Charles B., M.D., Ph.D.
Emory University School of Medicine
Atlanta, GA 30322-4990
404-727-8382


Fawcett, Jan A., M.D.
Rush Institute for Mental Well-Being
1725 West Harrison Street
Chicago, IL 60612
312-942-5372


Zajacka, John, M.D.
Rush Institute for Mental Well-Being
1725 West Harrison Street
Chicago, IL 60612
312-942-5592


Preskorn, Sheldon H., M.D.
University of Kansas School of Medicine
Wichita, KS 67214
316-261-2680


Post, Robert M., M.D.
NIMH Building 10
9000 Rockville Pike
Bethesda, MD 20892
301-496-4805


Rosenthal, Norman, M.D.
National Institute of Mental Health
Building 10, Room 4S239
Bethesda, MD 20892
301-496-2141


Wehr, Thomas A., M.D.
National Institute of Mental Health
Building 10, Room 4S239
Bethesda, MD 20892
301-496-2141


Covi, Lino, M.D.
2330 West Joppa Road
Lutherville, MD 21093
410-788-3230


Wender, Paul, M.D.
PMB 341
9 Bartlet Street
Andover, MA 01810
978-475-3202


Baldessarini, Ross J., M.D.
McLean Hospital
115 Mill Street
Belmont, MA 02178
517-855-3203


Cole, Jonathan O., M.D.
11586 Cambridge Street
Cambridge, MA 02138
617-789-3058


Fava, Maurizio, M.D.
Harvard Medical School
15 Parkman Street
Boston, MA 02114
617-726-3488


Nierenberg, Andrew A., M.D.
Massachusetts General Hospital
15 Parkman Street
Boston, MA 02114
617-726-4820


Rosenbaum, Jerrold F., M.D.
Massachusetts General Hospital
15 Parkman Street
Boston, MA 02114
617-726-3482


Greden, John F., M.D.
University of Michigan Medical Center
1500 East Medical Center Drive
Ann Arbor, MI 48109-0704
313-763-9629


Uhde, Thomas W., M.D.
Wayne State University
4201 St. Antoine
Detroit, MI 48201
313-577-2424


Rosenbaum, Alan H., M.D.
28800 Orchard Lake Road
Farmington Hills, MI 48334
248-539-0200


Cloninger, C. Robert, M.D.
Washington Univ. School of Medicine
4940 Childrens Place
St. Louis, MO 63110
314-362-7002


Giuffra, Luis, MD, PhD
Dept. of Psychiatry
One Barnes-Jewish Plaza
Ste. 16415
St. Louis, MO 63110
314-362-3901


Carroll, Bernard J., M.D., Ph.D.
John Umstead Hospital
Box 31
Butler, NC 27710
919-575-7801


Janowsky, David S., M.D.
University of North Carolina School of Medicine
Chapel Hill, NC 27599
919-966-0167


Prange Jr., Arthur J., M.D.
University of North Carolina School of Medicine
Chapel Hill, NC 27599
919-966-1489


Goodnick, Paul J., M.D.
Carrier Clinic
Belle Mead. NJ 08502
908-281-1484


Clayton, Paula J., M.D.
7 East Sunflower Circle
Santa Fe, NM 87501


Rifkin, Arthur, M.D.
Hillside Hospital
Glen Oaks, NY 11004
718-470-8075


Barchas, Jack D., M.D.
New York Hospital-Cornell Medical Center
525 East 68th Street
New York, NY 10021
212-746-3770


Goldberg, Ivan K., M.D.
1556 Third Avenue
New York, NY 10128
212-876-7800


Klein, Donald F., M.D.
New York State Psychiatric Institute
722 West 168th Street
New York, NY 10032
212-960-2306


Kocsis, James H., M.D.
New York Hospital
525 East 68th Street
New York, NY 10021
212-821-0723


Liebowitz, Michael R., M.D.
New York State Psychiatric Institute
722 West 168th Street
New York, NY 10032
212-960-2366


Landy. Douglas A., M.D.
Strong Health
300 Crittenden Blvd.
Rochester, NY 14642
5855-273-1708


Fink, Max, M.D.
P.O. Box 457
St. James, NY 11780
516-862-6651


Davidson, Jonathan R.T., M.D.
637 Totten Place
Chapel Hill, NC 27514
919-684-2880


Calabrese, Joseph, M.D.
11400 Euclid Street - Suite 200
Cleveland, OH 44106
216-844-2850


Keck, Paul E., M.D.
University of Cincinnati
231 Bethesda Avenue
Cincinnati, OH 45267
513-558-4316


Amsterdam, Jay, M.D.

3535 Market St. - Thirn Floor
Philadelphia, PA 19104
215-662-3462


Gyulai, Laszlo, M.D.
University of Pennsylvania
3535 Market St. - Suite 647
Philadelphia, PA 19104
215-746-6415


Gershon, Samuel, M.D.
Western Psychiatric Institute & Clinic
3811 O'Hara Street
Pittsburgh, PA 15213
412-624-2100


Kupfer, David J., M.D.
Western Psychiatric Institute & Clinic
3811 O'Hara Street
Pittsburgh, PA 15213
412-624-2100


Thase, Michael E., M.D.
Western Psychiatric Institute & Clinic
3811 O'Hara Street
Pittsburgh, PA 15213
412-624-5070


Keller, Martin B., M.D.
345 Blackstone Blvd.
Providence, RI 02906
401-455-6432


Brown, Walter A., M.D.
108 Driftwood Drive
Tiverton, RI 02878
401-624-1578


Ballenger, James C., M.D.
Medical University of South Carolina
171 Ashley Avenue
Charleston, SC 29425
803-796-1246


Hirschfeld, Robert M.A., M.D.
Dept. of Psychiatry & Behavioral Science
University of Texas Medical Branch
Galveston, TX 77555-0429
409-772-1011


Rush, A. John, M.D.
Univ. of Texas Southwestern Medical Center
6363 Forest Park Road, Suite B-225
Dallas, TX 75235
214-648-4600


Dunner, David L., M.D.
University of Washington
4225 Roosevelt Way, NE
Seattle, WA 98105
206-543-6768


Roy-Byrne, Peter P., M.D.
Harborview Medical Center
325 Ninth Avenue
Seattle, WA 98104
[206-897-4200]


Jefferson, James W., M.D.
8000 Excelsior Drive
Madison, WI 53717
608-836-3698

http://www.psycom.net/depression.central.psychiatrists.html

Revised 3/27/03

 

any references for opiates in resistant depression (nm) » jrbecker

Posted by joebob on April 8, 2004, at 11:14:51

In reply to Best Docs in US for Treatment-Resistant Depression, posted by jrbecker on April 8, 2004, at 10:36:39

 

Re: any references for opiates in resistant depression » joebob

Posted by jrbecker on April 8, 2004, at 16:51:55

In reply to any references for opiates in resistant depression (nm) » jrbecker, posted by joebob on April 8, 2004, at 11:14:51

only specially certified physicians are able to administer buprenorphine. SAMSHA's website has a list of these physicians, but as you know, most are very wary of the idea of opioid tx for major depression....

http://buprenorphine.samhsa.gov/bwns_locator/

 

thanks !!!! you're cool (nm) » jrbecker

Posted by joebob on April 9, 2004, at 9:49:38

In reply to Re: any references for opiates in resistant depression » joebob, posted by jrbecker on April 8, 2004, at 16:51:55

 

Re: any references for opiates in resistant depression » joebob

Posted by jerrympls on April 9, 2004, at 22:19:16

In reply to any references for opiates in resistant depression (nm) » jrbecker, posted by joebob on April 8, 2004, at 11:14:51

USE OF OPIATES FOR TREATMENT RESISTANT DEPRESSION

1: J Clin Psychiatry. 2001 Mar;62(3):205-6. 

Treatment of refractory major depression with tramadol monotherapy.

Shapira NA, Verduin ML, DeGraw JD.

Publication Types:
    Case Reports
    Letter

PMID: 11305709 [PubMed - indexed for MEDLINE]

2: Aust N Z J Psychiatry. 2000 Dec;34(6):1032-3. 

The efficacy of intramuscular tramadol as a rapid-onset antidepressant.

Spencer C.

Publication Types:
    Case Reports
    Letter

PMID: 11127616 [PubMed - indexed for MEDLINE]

3: Am J Psychiatry. 1999 Dec;156(12):2017. 

Treatment augmentation with opiates in severe and refractory major
depression.

Stoll AL, Rueter S.

Publication Types:
    Case Reports
    Letter

PMID: 10588427 [PubMed - indexed for MEDLINE]

4: J Clin Psychopharmacol. 1999 Aug;19(4):373-6. 

Long-term codeine use is associated with depressive symptoms.

Romach MK, Sproule BA, Sellers EM, Somer G, Busto UE.

Department of Pharmacology, Faculty of Pharmacy, University of Toronto,
Centre
for Addictions and Mental Health, Ontario, Canada.
myroslava.romach@utoronto.ca

A community survey was conducted among long-term (>6 months) users
of codeine-containing products to characterize chronic use of these
extensively consumed medications. Respondents recruited through newspaper
advertisements completed a mailed questionnaire. Three hundred thirty-nine completed questionnaires were obtained, yielding a response rate of 70%. Codeine dependence/abuse as defined by DSM-IV criteria was present in 41% of
the respondents. Two thirds of the subjects had sought help for mental
health problems, most often depression (70%). Scores on the Symptom
Checklist-90 subscales were modestly elevated, particularly on the Depression subscale (1.2 +/- 0.9). Long-term codeine use is strongly associated with dependence. Depression and depressive symptoms are common. These data suggest that dysphoric mood states may be significant in maintaining long-term codeine use.

PMID: 10440467 [PubMed - indexed for MEDLINE]

5: Biol Psychiatry. 1996 Jun 15;39(12):989-90. 

Buprenorphine for depression: the un-adoptable orphan.

Callaway E.

Publication Types:
    Editorial

PMID: 8780832 [PubMed - indexed for MEDLINE]

6: Am J Psychiatry. 1996 Jun;153(6):843-4. 

Mood alterations and tramadol.

Pinkofsky HB, Woodward RA, Reeves RR.

Publication Types:
    Case Reports
    Letter

PMID: 8633712 [PubMed - indexed for MEDLINE]

7: J Am Osteopath Assoc. 1996 Mar;96(3):156. 

Long-term narcotic use may complicate treatment for depression.

Tobe EH.

Publication Types:
    Letter

PMID: 8932590 [PubMed - indexed for MEDLINE]

8: Biomed Pharmacother. 1996;50(6-7):279-82. 

Treatment of depressive syndromes in detoxified drug addicts: use of
methadone.

Laqueille X, Bayle FJ, Spadone C, Jalfre V, Loo H.

Service Hospitalo-Universitaire de Sante Mentale et de Therapeutique,
Centre
Hospitalier Specialise Sainte-Anne, Paris, France.

Depressive syndromes are very frequent in drug-addicted patients. Their
study is particularly difficult on account of the toxic intake which disturbs
the clinical analysis. Methadone has improved our understanding of these
pathologies. In fact, methadone permits treatment of some depressive
disorders typically linked to addiction, such as a motivational symptoms and
depressive mood following intoxication. It brings to the fore the other mood
disorders which are often associated with drug intake.

Publication Types:
    Review
    Review, Tutorial

PMID: 8952868 [PubMed - indexed for MEDLINE]

9: J Clin Psychopharmacol. 1995 Feb;15(1):49-57. 

Buprenorphine treatment of refractory depression.

Bodkin JA, Zornberg GL, Lukas SE, Cole JO.

McLean Hospital, Consolidated Department of Psychiatry, Harvard Medical
School,
Belmont, MA 02178, USA.

Opiates were used to treat major depression until the mid-1950s. The
advent of opioids with mixed agonist-antagonist or partial agonist activity, with
reduced dependence and abuse liabilities, has made possible the reevaluation of
opioids for this indication. This is of potential importance for the population
of depressed patients who are unresponsive to or intolerant of
conventional antidepressant agents. Ten subjects with treatment-refractory,
unipolar, nonpsychotic, major depression were treated with the opioid partial
agonist buprenorphine in an open-label study. Three subjects were unable to
tolerate more than two doses because of side effects including malaise, nausea,
and dysphoria. The remaining seven completed 4 to 6 weeks of treatment and as
a group showed clinically striking improvement in both subjective and
objective measures of depression. Much of this improvement was observed by the end of 1 week of treatment and persisted throughout the trial. Four subjects
achieved complete remission of symptoms by the end of the trial (Hamilton Rating
Scale for Depression scores < or = 6), two were moderately improved, and
one deteriorated. These findings suggest a possible role for buprenorphine
in treating refractory depression.

Publication Types:
    Case Reports
    Clinical Trial

PMID: 7714228 [PubMed - indexed for MEDLINE]

10: J Subst Abuse Treat. 1990;7(1):51-4. 

Depressive symptoms during buprenorphine treatment of opioid abusers.

Kosten TR, Morgan C, Kosten TA.

Department of Psychiatry, Yale University School of Medicine, New Haven,
CT.

Among 40 opioid addicts treated as outpatients with sublingual
buprenorphine (2-8 mg daily) for a month, depressive symptoms significantly decreased in the 19 who were depressed at intake to treatment.

PMID: 2313769 [PubMed - indexed for MEDLINE]

11: Int Clin Psychopharmacol. 1988 Jul;3(3):255-66. 

Current and historical concepts of opiate treatment in psychiatric
disorders.

Weber MM, Emrich HM.

Max-Planck-Institut fur Psychiatrie, Munchen, Federal Republic of
Germany.

In recent years psychiatric research has rediscovered the theoretical
and clinical importance of opiates, especially for the understanding of
depressive disorders. However, opiate treatment is not a new therapeutic concept
in psychiatry. The use of opium for "melancholia" and "mania" may be traced to ancient classical medicine. After Paracelsus and Sydenham, the psychiatry of the German Romantic Era widely discussed therapeutic opium use with the Engelken family going on to develop a structured opium treatment of depression in the first half of the nineteenth century. Although the underlying scientific problems of psychiatric opium therapy were never solved, it gained an outstanding position as a practical treatment for over 100 years.

Publication Types:
    Historical Article

PMID: 3153713 [PubMed - indexed for MEDLINE]


This is the end of the thread.


Show another thread

URL of post in thread:


Psycho-Babble Medication | Extras | FAQ


[dr. bob] Dr. Bob is Robert Hsiung, MD, bob@dr-bob.org

Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.